Medicare Enrolled
Dr. Mark Laspina, D.O.
Urology Physician · Salem, MA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Laspina from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Laspina?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Laspina
Dr. Mark Laspina is an urology physician in Salem, MA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Laspina performed 7,686 Medicare services across 3,451 unique beneficiaries.
Between the years covered by Open Payments, Dr. Laspina received a total of $11,665 from 41 pharmaceutical and/or device companies across 367 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Laspina is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 11% volume in MA
$11,665 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,686
Medicare services
Top 11% in MA for urology physician
3,451
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~427 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 3,200 | $2 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
795 | $67 | $387 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
562 | $2 | $18 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
549 | $92 | $544 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
398 | $8 | $162 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
343 | $45 | $373 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
267 | $118 | $776 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
248 | $189 | $1,101 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 194 | $135 | $633 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
160 | $0 | $4 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
124 | $38 | $408 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
106 | $10 | $108 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
75 | $107 | $892 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
64 | $69 | $589 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
61 | $46 | $345 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
56 | $38 | $244 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
53 | $102 | $548 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
46 | $186 | $1,180 |
| Simple change of bladder tube | 43 | $73 | $428 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
40 | $78 | $510 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
38 | $132 | $762 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
34 | $438 | $2,639 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
28 | $131 | $675 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
28 | $41 | $419 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
28 | $24 | $166 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
19 | $20 | $100 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
17 | $254 | $2,038 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
17 | $91 | $1,609 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
17 | $337 | $2,029 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
17 | $66 | $407 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
16 | $576 | $3,408 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
16 | $60 | $385 |
| New patient office visit, complex (60-74 min) | 15 | $150 | $985 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
12 | $9 | $430 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
17.6% medium
81.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,665
Total received (2018-2024)
Avg $1,666/year across 7 years
Top 15% in MA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
367
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,232 (62.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,162 (35.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$271 (2.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$156
2023
$24
2022
$54
2021
$280
2020
$1,382
2019
$2,676
2018
$7,093
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Ferring Pharmaceuticals Inc.
$136
Astellas Pharma US Inc
$21
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Olympus Corporation
$4,162
Astellas Pharma US Inc
$1,497
NeoTract Inc.
$795
Janssen Biotech, Inc.
$758
AbbVie, Inc.
$581
Endo Pharmaceuticals Inc.
$382
Coloplast Corp
$359
TOLMAR Pharmaceuticals, Inc.
$293
Amgen Inc.
$287
Ferring Pharmaceuticals Inc.
$276
Avadel Specialty Pharmaceuticals, LLC
$247
PFIZER INC.
$228
AbbVie Inc.
$162
Blue Earth Diagnostics Limited
$151
Antares Pharma, Inc.
$143
MEDIVATION FIELD SOLUTIONS LLC
$125
TherapeuticsMD, Inc.
$116
Teleflex LLC
$112
DENTSPLY IH Inc.
$87
Allergan Inc.
$82
Aytu BioScience, Inc
$79
COLOPLAST CORP
$76
C. R. BARD, INC. & SUBSIDIARIES
$73
Acerus Pharmaceuticals Corporation
$70
Allergan, Inc.
$66
180 Medical, Inc.
$56
Retrophin, Inc.
$48
C. R. Bard, Inc. & Subsidiaries
$47
Rochester Medical Corporation
$37
Boston Scientific Corporation
$34
AMAG Pharmaceuticals, Inc.
$30
Augmenix, Inc.
$28
AstraZeneca Pharmaceuticals LP
$25
Bayer HealthCare Pharmaceuticals Inc.
$24
Tolmar, Inc.
$24
AKRIMAX PHARMACEUTICALS, LLC
$24
Aytu Bioscience, Inc
$22
Dendreon Pharmaceuticals LLC
$22
Medtronic USA, Inc.
$18
Merck Sharp & Dohme Corporation
$14
Janssen Pharmaceuticals, Inc
$3
Top 3 companies account for 55.3% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AVEED · Androgel · Axumin · BOTOX · BOTOX THERAPEUTIC · CONTINENCE CARE · ELIGARD · Erleada · FIRMAGON · GENERAL BPH · GENTLECATH · IMVEXXY · INTERSTIM · INTRAROSA · KEYTRUDA · LUPRON DEPOT · LoFric · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · NOCDURNA · Natesto · Noctiva · OTREXUP · Otrexup · PROVENGE · Prolia · SPEEDICATH · SWISS LITHOCLAST TRILOGY · SpaceOAR · Stendra · TITAN · TOROSA · TOVIAZ · Titan · Torosa · UroLift · UroLift System · VESICARE · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
181
Per 100K population
22.4
County median income
$99,431
Nearest hospital
NORTH SHORE MEDICAL CENTER -
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Laspina is a clinical cardiology specialist, with above-average Medicare volume (top 11% in MA), with low-engagement industry engagement in the top 15% of MA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Laspina experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Laspina performed 3,200 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Laspina receive payments from pharmaceutical companies?
Yes. Dr. Laspina received a total of $11,665 from 41 companies across 367 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Laspina's costs compare to other urology physicians in Salem?
Dr. Laspina's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Laspina) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Salem
Browse urology physicians in Salem ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in MA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in MA
Which MA urology physicians receive the most from drug and device companies.
By company
Olympus Corporation Payments to Doctors
See all physicians who received payments from Olympus Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology